Given the known immune regulation by Hsp70, hsc70, Grp78 and mortalin, they all represent rational targets for development of immune-based cancer prevention and treatment strategies that prime immune cells with the HSP70 antigens. The gene discussed is HSPA8; the disease is cancer.